EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability

Ziwei Gao iD, Jiei Sasaki iD, Tateki Suzuki iD, Shinsuke Sando iD, Takao Hashiguchi iD, Jumpei Morimoto iD

ChemMedChem · 2025

DOI: 10.1002/cmdc.202500532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2025. Verfasst von Ziwei Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry & Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan. Hauptthemen laut MEDLINE: Measles virus, Viral Fusion Proteins, Peptides, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Naito Foundation, AMED, The Uehara Memorial Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, a passively membrane‐permeable short peptide inhibitor targeting the measles virus fusion protein (MeV‐F) is reported. Measles virus (MeV) is highly contagious, yet no approved antiviral drugs are currently available. MeV‐F plays a crucial role in viral infection, making it an attractive target for drug development. The fusion inhibitor peptide (FIP) is a well‐known short peptide that binds to MeV‐F and prevents its structural rearrangement. However, improving both inhibitory activity and passive membrane permeability is essential for developing orally available MeV‐F inhibitors. Herein, FIP derivatives are explored through hydrogen‐to‐fluorine substitution and a derivative with enhanced inhibitory activity (IC 50 = 90 nM) and passive membrane permeability ( P e = 1.4 × 10 –6 cm s −1 ) was identified. This study highlights the potential of the long‐studied fusion inhibitor peptide as a promising lead compound for the development of orally available drugs against measles infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Measles virusViral Fusion ProteinsPeptidesAntiviral AgentsViral Fusion Protein InhibitorsCell Membrane PermeabilityHumansStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugMicrobial Sensitivity Tests

Stichwörter der Autor:innen

fluorinationfusion inhibitor peptidesmeasles virusmembrane permeability

Substanzen

Viral Fusion ProteinsPeptidesAntiviral AgentsViral Fusion Protein Inhibitors

Autor:innen und Institutionen

  • Department of Chemistry & Biotechnology, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan.
  • Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan.
  • Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8656, Japan.

ORCID-Profile: Ziwei Gao, Jiei Sasaki, Tateki Suzuki, Shinsuke Sando, Takao Hashiguchi, Jumpei Morimoto

Förderung

  • The Naito Foundation
  • AMED
  • The Uehara Memorial Foundation
  • NIGMS NIH HHS
  • CREST
  • JSPS Core-to-Core Program
  • JSPS KAKENHI
  • National Institute of Allergy and Infectious Diseases

Zitieren

APA

Gao, Z., Sasaki, J., Suzuki, T., Sando, S., Hashiguchi, T., & Morimoto, J. (2025). A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability. ChemMedChem. https://doi.org/10.1002/cmdc.202500532

Vancouver

Gao Z, Sasaki J, Suzuki T, Sando S, Hashiguchi T, Morimoto J. A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability. ChemMedChem. 2025. doi:10.1002/cmdc.202500532

BibTeX
@article{Gao2025,
  author = {Gao, Ziwei and Sasaki, Jiei and Suzuki, Tateki and Sando, Shinsuke and Hashiguchi, Takao and Morimoto, Jumpei},
  title = {A Short Peptide Inhibitor of Measles Virus Fusion Protein that Exhibits Passive Membrane Permeability},
  journal = {ChemMedChem},
  year = {2025},
  doi = {10.1002/cmdc.202500532}
}
Kostenlos starten →